ArticleHealth information science and systems2022
A framework for in-vivo human brain tumor detection using image augmentation and hybrid features.
Article in Health information science and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Efficient adaptive rotated object detection for 1D and QR barcodes.Scientific reports · 2026Article
- Multi channel fusion diffusion models for brain tumor MRI data augmentation.Scientific reports · 2025Article
- Memetic ant colony optimization for multi-constrained cognitive diagnostic test construction.Health information science and systems · 2024Article
- Intelligent antepartum fetal monitoring via deep learning and fusion of cardiotocographic signals and clinical data.Health information science and systems · 2023Article
- A Precise Method to Detect Post-COVID-19 Pulmonary Fibrosis Through Extreme Gradient Boosting.SN computer science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumor is caused by the uncontrolled and accelerated multiplication of cells in the brain. If not treated early enough, it can lead to death. Despite multiple significant efforts and promising research outcomes, accurate segmentation and classification of tumors remain a challenge. The changes in tumor location, shape, and size make brain tumor identification extremely difficult. An Extreme Gradient Boosting (XGBoost) algorithm using is proposed in this work to classify four subtypes of brain tumor-normal, gliomas, meningiomas, and pituitary tumors. Because the dataset was limited in size, image augmentation using a conditional Generative Adversarial Network (cGAN) was used to expand the training data. Deep features, Two-Dimensional Fractional Fourier Transform (2D-FrFT) features, and geometric features are fused together to extract both global and local information from the Magnetic Resonance Imaging (MRI) scans. The model attained enhanced performance with a classification accuracy of 98.79% and sensitivity of 98.77% for the test images. In comparison to state-of-the-art algorithms employing the Kaggle brain tumor dataset, the suggested model showed a considerable improvement. The improved results show the prominence of feature fusion and establish XGBoost as an appropriate classifier for brain tumor detection in terms on testing accuracy, sensitivity and Area under receiver operating characteristic (AUROC) curve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.